BioNexus Gene Lab Corp Files 2024 Annual Report Amendment

Ticker: BGLC · Form: 10-K/A · Filed: Apr 29, 2025 · CIK: 1737523

Bionexus Gene Lab CORP 10-K/A Filing Summary
FieldDetail
CompanyBionexus Gene Lab CORP (BGLC)
Form Type10-K/A
Filed DateApr 29, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: amendment, annual-report, sec-filing

TL;DR

BioNexus Gene Lab Corp filed an amendment to its 2024 10-K. Check for updates.

AI Summary

BioNexus Gene Lab Corp filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Wyoming and headquartered in Kuala Lumpur, Malaysia, operates in the medical laboratories sector. This filing was made on April 29, 2025, under SEC file number 001-41750.

Why It Matters

This amendment provides updated or corrected information for investors regarding BioNexus Gene Lab Corp's financial performance and operations for the 2024 fiscal year.

Risk Assessment

Risk Level: low — This filing is an amendment to a standard annual report and does not appear to contain significant new financial risks or disclosures.

Key Numbers

Key Players & Entities

FAQ

What specific information was amended in this 10-K/A filing?

The filing is an amendment to the annual report for the fiscal year ended December 31, 2024. Specific details of the amendments are not provided in the header information.

When was this amendment filed with the SEC?

This amendment was filed on April 29, 2025.

What is BioNexus Gene Lab Corp's primary business sector?

BioNexus Gene Lab Corp is classified under SERVICES-MEDICAL LABORATORIES [8071].

Where is BioNexus Gene Lab Corp headquartered?

The company's business and mailing address is in Kuala Lumpur, Malaysia.

In which U.S. state was BioNexus Gene Lab Corp incorporated?

BioNexus Gene Lab Corp was incorporated in Wyoming.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding BioNexus Gene Lab Corp (BGLC).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing